Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.32 billion. The enterprise value is $5.46 billion.
| Market Cap | 5.32B |
| Enterprise Value | 5.46B |
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Dec 26, 2024 |
Share Statistics
Balchem has 32.46 million shares outstanding. The number of shares has increased by 0.66% in one year.
| Current Share Class | 32.46M |
| Shares Outstanding | 32.46M |
| Shares Change (YoY) | +0.66% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 87.41% |
| Float | 32.28M |
Valuation Ratios
The trailing PE ratio is 37.60 and the forward PE ratio is 30.70. Balchem's PEG ratio is 3.23.
| PE Ratio | 37.60 |
| Forward PE | 30.70 |
| PS Ratio | 5.39 |
| Forward PS | 6.52 |
| PB Ratio | 4.20 |
| P/TBV Ratio | 19.02 |
| P/FCF Ratio | 34.75 |
| P/OCF Ratio | 28.40 |
| PEG Ratio | 3.23 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.45, with an EV/FCF ratio of 35.68.
| EV / Earnings | 38.27 |
| EV / Sales | 5.54 |
| EV / EBITDA | 22.45 |
| EV / EBIT | 27.40 |
| EV / FCF | 35.68 |
Financial Position
The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.64 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | 1.36 |
| Interest Coverage | 15.85 |
Financial Efficiency
Return on equity (ROE) is 11.99% and return on invested capital (ROIC) is 8.67%.
| Return on Equity (ROE) | 11.99% |
| Return on Assets (ROA) | 7.66% |
| Return on Invested Capital (ROIC) | 8.67% |
| Return on Capital Employed (ROCE) | 12.94% |
| Revenue Per Employee | $724,416 |
| Profits Per Employee | $104,887 |
| Employee Count | 1,361 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 4.77 |
Taxes
In the past 12 months, Balchem has paid $42.58 million in taxes.
| Income Tax | 42.58M |
| Effective Tax Rate | 22.97% |
Stock Price Statistics
The stock price has increased by +0.78% in the last 52 weeks. The beta is 0.89, so Balchem's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +0.78% |
| 50-Day Moving Average | 159.03 |
| 200-Day Moving Average | 164.83 |
| Relative Strength Index (RSI) | 66.88 |
| Average Volume (20 Days) | 201,350 |
Short Selling Information
The latest short interest is 488,378, so 1.50% of the outstanding shares have been sold short.
| Short Interest | 488,378 |
| Short Previous Month | 479,238 |
| Short % of Shares Out | 1.50% |
| Short % of Float | 1.51% |
| Short Ratio (days to cover) | 2.76 |
Income Statement
In the last 12 months, Balchem had revenue of $985.93 million and earned $142.75 million in profits. Earnings per share was $4.36.
| Revenue | 985.93M |
| Gross Profit | 352.98M |
| Operating Income | 199.33M |
| Pretax Income | 147.82M |
| Net Income | 142.75M |
| EBITDA | 243.33M |
| EBIT | 199.33M |
| Earnings Per Share (EPS) | $4.36 |
Balance Sheet
The company has $65.43 million in cash and $207.68 million in debt, giving a net cash position of -$142.25 million or -$4.38 per share.
| Cash & Cash Equivalents | 65.43M |
| Total Debt | 207.68M |
| Net Cash | -142.25M |
| Net Cash Per Share | -$4.38 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 39.07 |
| Working Capital | 226.72M |
Cash Flow
In the last 12 months, operating cash flow was $187.33 million and capital expenditures -$34.25 million, giving a free cash flow of $153.08 million.
| Operating Cash Flow | 187.33M |
| Capital Expenditures | -34.25M |
| Free Cash Flow | 153.08M |
| FCF Per Share | $4.72 |
Margins
Gross margin is 35.80%, with operating and profit margins of 20.22% and 14.48%.
| Gross Margin | 35.80% |
| Operating Margin | 20.22% |
| Pretax Margin | 18.80% |
| Profit Margin | 14.48% |
| EBITDA Margin | 24.68% |
| EBIT Margin | 20.22% |
| FCF Margin | 15.53% |
Dividends & Yields
This stock pays an annual dividend of $0.87, which amounts to a dividend yield of 0.54%.
| Dividend Per Share | $0.87 |
| Dividend Yield | 0.54% |
| Dividend Growth (YoY) | 10.13% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 19.96% |
| Buyback Yield | -0.66% |
| Shareholder Yield | -0.13% |
| Earnings Yield | 2.68% |
| FCF Yield | 2.88% |
Analyst Forecast
The average price target for Balchem is $189.00, which is 15.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $189.00 |
| Price Target Difference | 15.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 10 and a Piotroski F-Score of 7.
| Altman Z-Score | 10 |
| Piotroski F-Score | 7 |